Design of the “EAST” strategy in patients with symptomatic intracranial atherosclerotic stenosis

Design of the “EAST” strategy in patients with symptomatic intracranial atherosclerotic stenosis

IntroductionThere is a high risk of stroke occurrence and recurrence in patients with intracranial atherosclerotic stenosis (ICAS) despite aggressive medical therapy. Evolocumab is a monoclonal antibody which can inhibit proprotein convertase subtilisin-kexin type 9 (PCSK9) and effectively reduce th...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiaqi Dai, Haobo Zhao, Xinyu Chen, Ping Nie, Jie Gong, Min Wang, Kezhong Zhang, Zhaolu Wang, Hua Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Neurology
Subjects:
statin
intracranial atherosclerotic stenosis
treatment
HR-vwMRI
PCSK9 inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1520356/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1520356/full

Similar Items